Novartis AG (NVS)
161.01
-4.14
(-2.51%)
USD |
NYSE |
Mar 05, 16:00
157.27
-3.74
(-2.32%)
Pre-Market: 08:08
Novartis Cash from Investing (TTM) : -4.902B for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Roche Holding AG | -10.89B |
| Amgen, Inc. | -1.943B |
| AstraZeneca PLC | -7.111B |
| Gilead Sciences, Inc. | -4.793B |
| GSK Plc | -7.740B |